68Ga-FAPI-PET/CT in extra-cervical CUP: Head-to-Head Comparison of 68Ga-FAPI-46 with 18F-FDG in 13 patients
European Journal of Nuclear Medicine and Molecular Imaging · 2026-08 · 53 (10) · 5833-5843
DOI: 10.1007/s00259-026-07916-0 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 22.05.2026. Verfasst von Anna-Maria Spektor und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University Medical Center, Johannes Gutenberg University Mainz, Langenbeckstraße 1, 55131, Mainz, Germany, Germany. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Radiopharmaceuticals, Neoplasms, Unknown Primary. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsmedizin der Johannes Gutenberg-Universität Mainz.
Abstract (Originalsprache)
Purpose
Oncological treatment in a substantial portion of patients with cancer of unknown primary (CUP) remains challenging due to limitations of conventional imaging and positron emission tomography/computed tomography with 18 Fluor-fluorodeoxyglucose ( 18 F-FDG-PET/CT). In head and neck-like CUP (HNCUP), several studies found significantly higher tracer-uptake and detection rates of primary tumors in 68 Gallium-labeled fibroblast activation protein inhibitor-PET/CT ( 68 Ga-FAPI-PET/CT). Here, we address a gap in CUP literature by retrospectively evaluating the diagnostic accuracy of both tracer in a head-to-head comparison of patients with single-site and oligometastatic extra-cervical CUP.
Methods
13 patients with extra-cervical CUP underwent both 18 F-FDG- and 68 Ga-FAPI-PET/CT. Suspicious PET-positive lesions were delineated using the volume of interest-technique (50%-isocontour) followed by analysis of maximum and mean standardized uptake values (SUVmax/mean), target-to-background ratios (TBRmax/mean) and tumor-to-tissue ratios (TTRmax/mean). Descriptive analysis was performed and log-transformation was applied to meet model assumptions and stabilize variance. The difference between log-transformed 68 Ga-FAPI- and 18 F-FDG-uptake values was used as outcome variables.
Results
21 metastases of 3 patients with single-site and 6 patients with oligometastasized CUP were analyzed. 4 patients with previously extirpated metastases showed no uptake. No increased detection rate of primary tumors could be observed by either tracer. Differences of TBRmax in all metastatic sites and of TTRmax in organ metastases were significant. 68 Ga-FAPI-PET/CT lead to detection of 5/21 additional metastases which were not clearly distinguishable in 18 F-FDG-PET/CT.
Conclusion
Due to higher tissue contrast in organs, our findings suggest that 68 Ga-FAPI-PET/CT appears favourable compared to 18 F-FDG-PET/CT particularly in patients with suspected distant metastases other than lymph nodes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, University Medical Center, Johannes Gutenberg University Mainz, Langenbeckstraße 1, 55131, Mainz, Germany, Germany.
- University Cancer Center, University Medical Center, Johannes Gutenberg University, Langenbeckstr. 1, 55131, Mainz, Germany. Sergio.ZapataBonilla@unimedizin-mainz.de.
- Institute of Medical Biometry, Epidemiology and Informatics, Johannes Gutenberg University Mainz, Mainz, Germany.
- Department of Diagnostic and Interventional Radiology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
- Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
- Department of Pathology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
ORCID-Profile: Anna-Maria Spektor, Sergio Armando Zapata Bonilla
Förderung
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Zitieren
APA
Spektor, A. M., Zapata Bonilla, S. A., Mildenberger, P., Kilburg, A., Driess, D., Winter, E., Kloth, M., Schreckenberger, M., Bäuerle, T., Kindler, T., Haberkorn, U., Pouyiourou, M., Krämer, A., Bochtler, T., & Röhrich, M. (2026). 68Ga-FAPI-PET/CT in extra-cervical CUP: Head-to-Head Comparison of 68Ga-FAPI-46 with 18F-FDG in 13 patients. European Journal of Nuclear Medicine and Molecular Imaging, 53(10), 5833-5843. https://doi.org/10.1007/s00259-026-07916-0
Vancouver
Spektor AM, Zapata Bonilla SA, Mildenberger P, Kilburg A, Driess D, Winter E, et al. 68Ga-FAPI-PET/CT in extra-cervical CUP: Head-to-Head Comparison of 68Ga-FAPI-46 with 18F-FDG in 13 patients. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(10):5833-5843. doi:10.1007/s00259-026-07916-0
BibTeX
@article{Spektor2026,
author = {Spektor, Anna-Maria and Zapata Bonilla, Sergio Armando and Mildenberger, Philipp and Kilburg, Anton and Driess, Daniela and Winter, Erik and Kloth, Michael and Schreckenberger, Mathias and Bäuerle, Tobias and Kindler, Thomas and Haberkorn, Uwe and Pouyiourou, Maria and Krämer, Alwin and Bochtler, Tilmann and Röhrich, Manuel},
title = {68Ga-FAPI-PET/CT in extra-cervical CUP: Head-to-Head Comparison of 68Ga-FAPI-46 with 18F-FDG in 13 patients},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {10},
pages = {5833--5843},
doi = {10.1007/s00259-026-07916-0}
}
EUVIMED